Anti-vascular endothelial growth factor (VEGF) antibodies and programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1) antibodies are novel and commonly used treatments for cancers (1, 2). The gene discussed is VEGFA; the disease is cancer.